Compare ETFs: LON:BTEC vs. IBB
LON:BTEC
IBB
Comparison
Average Return
In the past year, LON:BTEC returned a total of 38.72%, which is significantly higher than IBB's 33.03% return. Over the past 5 years, LON:BTEC has had annualized average returns of 3.64%, compared to 1.34% for IBB. These numbers are adjusted for stock splits and include dividends.
Top 25 Holdings
| LON:BTEC - iShares NASDAQ US Biotechnology UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | AMGN | Amgen Inc. | 7.31% |
| 2 | GILD | Gilead Sciences, Inc. | 7.21% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.14% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.25% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.24% |
| 6 | INSM | Insmed Incorporated | 2.33% |
| 7 | BIIB | Biogen Inc. | 2.17% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.15% |
| 9 | UTHR | United Therapeutics Corporation | 1.99% |
| 10 | ARGX | argenx SE | 1.77% |
| 11 | RPRX | Royalty Pharma plc | 1.70% |
| 12 | MRNA | Moderna, Inc. | 1.61% |
| 13 | ROIV | Roivant Sciences Ltd. | 1.57% |
| 14 | ILMN | Illumina, Inc. | 1.57% |
| 15 | INCY | Incyte Corporation | 1.51% |
| 16 | SMMT | Summit Therapeutics Inc. | 1.37% |
| 17 | VTRS | Viatris Inc. | 1.35% |
| 18 | BBIO | BridgeBio Pharma, Inc. | 1.14% |
| 19 | n/a | Ascendis Pharma | 1.13% |
| 20 | NBIX | Neurocrine Biosciences, Inc. | 1.02% |
| 21 | IONS | Ionis Pharmaceuticals, Inc. | 0.97% |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 0.97% |
| 23 | BNTX | BioNTech SE | 0.96% |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.94% |
| 25 | EXEL | Exelixis, Inc. | 0.93% |
| View LON:BTEC holdings | |||
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | AMGN | Amgen Inc. | 7.30% |
| 2 | GILD | Gilead Sciences, Inc. | 7.24% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.22% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.88% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.67% |
| 6 | ARGX | argenx SE | 3.28% |
| 7 | INSM | Insmed Incorporated | 2.66% |
| 8 | BIIB | Biogen Inc. | 2.48% |
| 9 | NTRA | Natera, Inc. | 2.43% |
| 10 | RVMD | Revolution Medicines, Inc. | 2.31% |
| 11 | UTHR | United Therapeutics Corporation | 2.23% |
| 12 | ONC | BeOne Medicines AG | 1.96% |
| 13 | INCY | Incyte Corporation | 1.78% |
| 14 | ILMN | Illumina, Inc. | 1.74% |
| 15 | MRNA | Moderna, Inc. | 1.57% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.25% |
| 17 | GMAB | Genmab A/S | 1.18% |
| 18 | NBIX | Neurocrine Biosciences, Inc. | 1.16% |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 1.07% |
| 20 | BBIO | BridgeBio Pharma, Inc. | 1.07% |
| 21 | EXEL | Exelixis, Inc. | 1.04% |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.00% |
| 23 | ASND | Ascendis Pharma A/S | 0.94% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 0.93% |
| 25 | USD | USD CASH | 0.90% |
| View IBB holdings | |||